ArticleJournal of clinical medicine2025

Switching from Aflibercept to Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration: Short-Term Results from Real-Life Study.

Jan Kucharczuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.